Middle East & Africa Colorectal Cancer Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories) 


No. of Pages: 162    |    Report Code: BMIRE00026182    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Colorectal Cancer Market

The colorectal cancer market in the Middle East & Africa is expected to grow from US$ 885.81 million in 2022 to US$ 1,076.92 million by 2028; it is estimated to grow at a CAGR of 2.5% from 2022 to 2028.

 

Numerous benefits offered by generic drugs is among the major factor driving the growth of the Middle East & Africa colorectal cancer market. Generic drugs are alternatives to branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers do not invest in developing and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, generic drugs are cheaper than their branded counterparts. Generic drugs have the same dosage, effects and side effects, route of administration, risks, safety, and strength as the original branded drugs.

 

Generic drugs are important in oncology because some anticancer drugs are only offered as generics. Patients are likely to abandon branded prescriptions associated with their higher prices. Generic drugs for cancer treatment are profitable for manufacturers and patients due to their affordability and efficacy, especially in developing countries in the Middle East & Africa, where the paying capacity of consumers is relatively low. Thus, the preference for generic drugs among consumers and the high adoption of generic drugs for colorectal cancer treatment are fueling the growth of the colorectal cancer market in the region.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa colorectal cancer market at a substantial CAGR during the forecast period.

 

 Middle East & Africa Colorectal Cancer

 

Market Revenue and Forecast to 2028 (US$ Million)

 Middle East & Africa Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

Middle East & Africa Colorectal Cancer Strategic Insights

Strategic insights for the Middle East & Africa Colorectal Cancer provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-colorectal-cancer-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Colorectal Cancer Report Scope

Report Attribute Details
Market size in 2022 US$ 885.81 Million
Market Size by 2028 US$ 1,076.92 Million
Global CAGR (2022 - 2028) 2.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Modality
  • Diagnosis Type
  • Therapy Type
  • Imaging Type
By End User
  • Hospitals and Diagnostic & Research Laboratories
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Get more information on this report

    Middle East & Africa Colorectal Cancer Regional Insights

    The geographic scope of the Middle East & Africa Colorectal Cancer refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-colorectal-cancer-market-geography.webp
    Get more information on this report

     

     

     

    Middle East & Africa Colorectal Cancer Market Segmentation

     

    The Middle East & Africa colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Middle East & Africa colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Middle East & Africa colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Middle East & Africa colorectal cancer market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest market share in 2022.

     

    Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the Middle East & Africa colorectal cancer market. 

    The List of Companies - Middle East & Africa Colorectal Cancer Market

    1. Abbott
    2. Amgen Inc.
    3. Bruker Corporation
    4. Epigenomics AG
    5. F. Hoffmann-La Roche AG
    6. Quest Diagnostics  
    7. VolitionRx Limited
    Frequently Asked Questions
    How big is the Middle East & Africa Colorectal Cancer Market?

    The Middle East & Africa Colorectal Cancer Market is valued at US$ 885.81 Million in 2022, it is projected to reach US$ 1,076.92 Million by 2028.

    What is the CAGR for Middle East & Africa Colorectal Cancer Market by (2022 - 2028)?

    As per our report Middle East & Africa Colorectal Cancer Market, the market size is valued at US$ 885.81 Million in 2022, projecting it to reach US$ 1,076.92 Million by 2028. This translates to a CAGR of approximately 2.5% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Colorectal Cancer Market report typically cover these key segments-

  • Modality (Diagnosis Type, Therapy Type, Imaging Type)
  • End User (Hospitals and Diagnostic & Research Laboratories)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Colorectal Cancer Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Colorectal Cancer Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Middle East & Africa Colorectal Cancer Market?

    The Middle East & Africa Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Who should buy this report?

    The Middle East & Africa Colorectal Cancer Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.